Lonza has launched a new set of immunogenicity, stability and protein engineering services designed to improve the quality, safety, efficacy and manufacturability of antibodies, therapeutic proteins and vaccines. The Applied Protein Services platform complements the company's process development and manufacturing capabilities while advancing its efforts to incorporate Quality by Design (QbD) principles.
Lonza
Thursday, 10 June 2010
Lonza adds development services
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment